Submitted by Abbi Abbioui on Tue, 21/12/2021 - 13:12
Congratulations to Dr David Bulmer, who has recently signed a 3-year collaborative research agreement with GlaxoSmithKline to look at the utility of drugs targeting orphan G protein coupled receptors for the treatment of digestive diseases.